Log in

Electromed Stock Forecast, Price & News

-0.13 (-1.41 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $9.12
50-Day Range N/A
52-Week Range
Now: $9.12
Volume37,026 shs
Average Volume146,277 shs
Market Capitalization$78.44 million
P/E Ratio19.00
Dividend YieldN/A
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.45 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
Phone952 758 9299



Sales & Book Value

Annual Sales$32.47 million
Cash Flow$0.61 per share
Book Value$3.57 per share


Net Income$4.16 million


Market Cap$78.44 million
Next Earnings DateN/A
OptionableNot Optionable
-0.13 (-1.41 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ELMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Electromed (NYSE:ELMD) Frequently Asked Questions

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSE:ELMD) posted its earnings results on Tuesday, August, 25th. The company reported $0.15 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.15) by $0.30. The business had revenue of $6.88 million for the quarter. Electromed had a net margin of 12.82% and a return on equity of 14.48%.
View Electromed's earnings history

Who are some of Electromed's key competitors?

Who are Electromed's key executives?

Electromed's management team includes the following people:
  • Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 64, Pay $547.57k)
  • Mr. Michael Joseph MacCourt, CFO, Treasurer & Sec. (Age 42)
  • Mr. Bud Reeves, VP of Sales
  • Mr. William J. George, Sec. (Age 71)
  • Ms. Kathryn Thompson, VP of Reimbursement

What is Electromed's stock symbol?

Electromed trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELMD."

How do I buy shares of Electromed?

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Electromed's stock price today?

One share of ELMD stock can currently be purchased for approximately $9.12.

How big of a company is Electromed?

Electromed has a market capitalization of $78.44 million and generates $32.47 million in revenue each year. The company earns $4.16 million in net income (profit) each year or $0.47 on an earnings per share basis. Electromed employs 120 workers across the globe.

What is Electromed's official website?

The official website for Electromed is smartvest.com.

How can I contact Electromed?

Electromed's mailing address is 500 SIXTH AVENUE NW, NEW PRAGUE MN, 56071. The company can be reached via phone at 952 758 9299.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.